We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Cardiology

Journal Scan / Research · March 01, 2021

Metformin Is Associated with a Lower Risk of AF and Ventricular Arrhythmias Compared With Sulfonylureas

Circulation: Arrhythmia and Electrophysiology

 

Additional Info

Circulation: Arrhythmia and Electrophysiology
Metformin Is Associated with a Lower Risk of Atrial Fibrillation and Ventricular Arrhythmias Compared to Sulfonylureas: An Observational Study
Circ Arrhythm Electrophysiol 2021 Feb 07;[EPub Ahead of Print], A Ostropolets, PA Elias, MV Reyes, EY Wan, UB Pajvani, G Hripcsak, JP Morrow

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading